Literature DB >> 23239432

Hyperinsulinemic hypoglycemia of infancy in Sotos syndrome.

Terumichi Matsuo1, Kenji Ihara, Masayuki Ochiai, Tadamune Kinjo, Yoko Yoshikawa, Kanako Kojima-Ishii, Marie Noda, Hiroshi Mizumoto, Maiko Misaki, Kyoko Minagawa, Koji Tominaga, Toshiro Hara.   

Abstract

Sotos syndrome (OMIM #117550) is a congenital syndrome characterized by overgrowth with advanced bone age, macrocephaly, and learning difficulties. Endocrine complications of this syndrome have not yet been fully described in previous reports. We here investigated the clinical manifestations of Sotos syndrome in Japanese patients who presented with hyperinsulinemic hypoglycemia of infancy. We recruited patients diagnosed as having Sotos syndrome who presented with the complication of hyperinsulinemia during the neonatal period using a survey of the abstracts of Pediatric Meetings in domestic areas of Japan from 2007 to 2011. As a result, five patients (four females and one male) were recruited to evaluate the clinical presentation of Sotos syndrome by reference to the clinical record of each patient. A 5q35 deletion including the NSD1 gene was detected in all patients. Major anomalies in the central nervous, cardiovascular, and genito-urinary systems were frequently found. Hypoglycemia occurred between 0.5 and 3 hr after birth and high levels of insulin were initially found within 3 days of birth. The patients were treated with intravenous glucose infusion at a maximum rate of 4.6-11.0 mg/kg/min for 12-49 days. Three of the five patients required nasal tube feeding. One patient received medical treatment with diazoxide. This study shows that patients with Sotos syndrome may present with transient hyperinsulinemic hypoglycemia in the neonatal period.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239432     DOI: 10.1002/ajmg.a.35657

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

2.  Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations.

Authors:  Katheryn Grand; Christina Gonzalez-Gandolfi; Amanda M Ackermann; Deema Aljeaid; Emma Bedoukian; Lynne M Bird; Diva D De Leon; Jullianne Diaz; Robert J Hopkin; Sejal P Kadakia; Beth Keena; Karen O Klein; Ian Krantz; Eyby Leon; Katherine Lord; Carey McDougall; Livija Medne; Cara M Skraban; Charles A Stanley; Jennifer Tarpinian; Elaine Zackai; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet A       Date:  2019-02-04       Impact factor: 2.802

Review 3.  Congenital hyperinsulinism disorders: Genetic and clinical characteristics.

Authors:  Elizabeth Rosenfeld; Arupa Ganguly; Diva D De Leon
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-08-14       Impact factor: 3.908

Review 4.  Hypoglycemia due to PI3K/AKT/mTOR signaling pathway defects: two novel cases and review of the literature.

Authors:  Evelina Maines; Roberto Franceschi; Diego Martinelli; Fiorenza Soli; Francesca Romana Lepri; Giovanni Piccoli; Massimo Soffiati
Journal:  Hormones (Athens)       Date:  2021-04-20       Impact factor: 2.885

Review 5.  Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.

Authors:  Thomas I Hewat; Matthew B Johnson; Sarah E Flanagan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.